Overview

An End to the Yom Kippur (and Ramadan) Headache

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
Fasting is a known trigger for headache. People who fast to comply with religious edict have been shown to be prone to headache which becomes more likely to occur with increasing length of fasting, and in people prone to headache. This has been documented as 'Yom Kippur Headache' and 'First of Ramadan Headache.' We performed a study to test the hypothesis that Rofecoxib, a pain medicine and anti-inflammatory, with a prolonged duration of action would prevent or attenuate headache when taken just prior to the complete (no food or drink) 25 hour fast of Yom Kippur.
Phase:
N/A
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Rofecoxib